Skip to content

Kinds of news

Trial results Latest

Topline, interim and final results.

2 picks0 in the past 30 days5 collected in total

Updated

Top picks for Trial results

14 SepMon1–2
  1. STAT: psychedelics78

    Definium says LSD therapy DT120 eased anxiety in second late-stage trial

    Definium Therapeutics said its LSD therapy DT120 helped patients with anxiety in a second late-stage trial.

    Why it matters: The reported 5.1-point gap between DT120 and placebo mirrors the company's first late-stage anxiety study, so the pending regulatory filing will test whether that effect size holds up in a review.

22 JunMon
  1. STAT: psychedelics83

    Definium says LSD therapy DT120 helped major depression in first Phase 3 trial

    Definium Therapeutics said on Monday that its LSD therapy DT120 significantly helped patients with major depression in its first Phase 3 trial. Six weeks after a single dose.

    Why it matters: The topline gives the first Phase 3 readout for an LSD-based depression treatment, so the size of the placebo gap and the waning at 12 weeks are the numbers that will shape the next regulatory step.